Stockreport

ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™

ImmuCell Corporation  (ICCC) 
US:NASDAQ Investor Relations: immucell.com/investors
PDF Second Submission Anticipated Around Q3 2020 PORTLAND, Maine, Aug. 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a [Read more]